Galapagos NV logo

Galapagos NV - ADR

1
NEW
NAS:GLPG (Belgium)   ADR
$ 26.41 -2.15 (-7.52%) 07:08 PM EST
5.67
P/B:
0.55
Enterprise V:
$ -1.97B
Volume:
554.21K
Avg Vol (2M):
129.45K
Trade In:
Volume:
554.21K
Avg Vol (2M):
129.45K

Business Description

Description
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.
Name Current Vs Industry Vs History
Cash-To-Debt 315.5
Equity-to-Asset 0.68
Debt-to-EBITDA 0.38
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.72
Distress
Grey
Safe
Beneish M-Score 4.6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.62
9-Day RSI 36.94
14-Day RSI 43.23
6-1 Month Momentum % 1.2
12-1 Month Momentum % -13.91

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.05
Quick Ratio 9.87
Cash Ratio 9.4
Days Inventory 720.88
Days Sales Outstanding 61.58
Days Payable 1477.48

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.2
Shareholder Yield % 0.48

Financials (Next Earnings Date:2024-10-31)

GLPG's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:GLPG

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Galapagos NV Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 276.058
EPS (TTM) ($) 4.662
Beta 0.25
Volatility % 29.22
14-Day RSI 43.23
14-Day ATR ($) 0.693983
20-Day SMA ($) 29.531
12-1 Month Momentum % -13.91
52-Week Range ($) 24.16 - 42.455
Shares Outstanding (Mil) 65.9

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Galapagos NV Filings

Filing Date Document Date Form
No Filing Data

Galapagos NV Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Galapagos NV Frequently Asked Questions

What is Galapagos NV(GLPG)'s stock price today?
The current price of GLPG is $26.41. The 52 week high of GLPG is $42.46 and 52 week low is $24.16.
When is next earnings date of Galapagos NV(GLPG)?
The next earnings date of Galapagos NV(GLPG) is 2024-10-31.
Does Galapagos NV(GLPG) pay dividends? If so, how much?
Galapagos NV(GLPG) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1